Legacy Financial Strategies’s Thermo Fisher Scientific TMO Stock Holding History

Legacy Financial Strategies’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$375K	Buy	555 +1	+0.2%	+$594	0.06%	103
2026 Q2	$278K	Sell	554 -44	-7%	-$21.1K	0.04%	125
2026 Q1	$294K	Buy	598 +15	+3%	+$8.14K	0.05%	114
2025 Q4	$338K	Buy	583 +8	+1%	+$4.52K	0.06%	96
2025 Q3	$279K	Buy	575 +36	+7%	+$16.8K	0.05%	112
2025 Q2	$219K	Buy	+539	New	+$225K	0.04%	119
2024 Q4	–	Sell	-380	Closed	-$235K	–	125
2024 Q3	$235K	Buy	380 +5	+1%	+$2.96K	0.05%	105
2024 Q2	$201K	Buy	+375	New	+$215K	0.05%	95

Other funds holding TMO

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.93B AUM 11.81% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $6.57B AUM 14.15% 1-Year Est. Return

GIA

Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.91B AUM 26.66% 1-Year Est. Return

CIPU

Caledonia Investments plc (UK) London England, United Kingdom $890M AUM 1.23% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Legacy Financial Strategies's TMO Position: Q3 2026 in Review

Legacy Financial Strategies increased its Thermo Fisher Scientific (TMO) stake by 0.18% in Q3 2026, buying an estimated $594 and bringing the position to 555 shares worth $375K. The position accounts for 0.06% of the portfolio, ranked #103.

Legacy Financial Strategies first reported a position in TMO in Q2 2024 and has held it in 8 quarters since. 375 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

Legacy Financial Strategies held 555 shares of Thermo Fisher Scientific worth $375K as of Q3 2026.
Legacy Financial Strategies bought 1 Thermo Fisher Scientific share in Q3 2026, an estimated $594.
Thermo Fisher Scientific made up 0.06% of Legacy Financial Strategies's portfolio in Q3 2026, its #103 holding.
Legacy Financial Strategies first reported a position in Thermo Fisher Scientific in Q2 2024 and has held it in 8 quarters since.
375 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Legacy Financial Strategies's 13F filing for Q3 2026, filed 15 Oct 2026.